(Q33333176)

25 July 2017

Occurrence and clinical significance of pseudothrombocytopenia during abciximab therapy (English)

1 reference

25 July 2017

Pseudothrombocytopenia

0 references

author

Eric J. Topol

3

1 reference

25 July 2017

8

R M Califf

1 reference

25 July 2017

D C Sane

1

1 reference

25 July 2017

L V Damaraju

2

1 reference

25 July 2017

C F Cabot

4

1 reference

25 July 2017

M A Mascelli

5

1 reference

25 July 2017

R A Harrington

6

1 reference

25 July 2017

M L Simoons

7

1 reference

25 July 2017

language of work or name

English

0 references

publication date

1 July 2000

1 reference

Journal of the American College of Cardiology

25 July 2017

1 reference

25 July 2017

36

1 reference

25 July 2017

75-83

1 reference

25 July 2017

1

1 reference

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

25 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900688-4

7 January 2021

Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900688-4

7 January 2021

Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900688-4

7 January 2021

Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900688-4

7 January 2021

Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900688-4

7 January 2021

A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900688-4

7 January 2021

Occurrence and clinical significance of thrombocytopenia in a population undergoing high-risk percutaneous coronary revascularization. Evaluation of c7E3 for the Prevention of Ischemic Complications (EPIC) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900688-4

7 January 2021

Acute profound thrombocytopenia after C7E3 Fab (abciximab) therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900688-4

7 January 2021

A new type of pseudothrombocytopenia: EDTA-mediated agglutination of platelets bearing Fab fragments of a chimaeric antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900688-4

7 January 2021

Pseudothrombocytopenia in plateletpheresis donors

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900688-4

7 January 2021

EDTA-dependent pseudothrombocytopaenia: a 12-month epidemiological study.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900688-4

7 January 2021

Pseudothrombocytopenia: a laboratory artifact with potentially serious consequences

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900688-4

7 January 2021

Incidence and diagnosis of EDTA-dependent pseudothrombocytopenia in a consecutive outpatient population referred for isolated thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900688-4

7 January 2021

IgG platelet antibodies in EDTA-dependent pseudothrombocytopenia bind to platelet membrane glycoprotein IIb.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900688-4

7 January 2021

EDTA-dependent pseudothrombocytopenia: a clinical and epidemiological study of 112 cases, with 10-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900688-4

7 January 2021

EDTA-dependent pseudothrombocytopenia. Association with antiplatelet and antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900688-4

7 January 2021

Aminoglycosides prevent and dissociate the aggregation of platelets in patients with EDTA-dependent pseudothrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900688-4

7 January 2021

10.1016/S0735-1097(00)00688-4

Identifiers

DOI

1 reference

release_by6dqimnnvdrpneedgku5p6edm

25 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/by6dqimnnvdrpneedgku5p6edm

24 November 2022

mapped directly with Wikidata item

1 reference